Genotype (GT) 3 has emerged as a difficultto- treat viral strain, achieving Sustained Virologic Response (SVR) rates lower than other genotypes. Data about GT3-infected HIV patients are scarce either from clinical trials or real life. Describe the outcome of GT3 co-infected individuals treated with DAA; explore factors associated with virological failure.
Genotype 3 Infection in HIV/HCV co-infected subjects in the DAA era: Real life data from the ICONA/HepaICONA Foundation cohorts
G. Nunnari;G. F. Pellicanò
2018-01-01
Abstract
Genotype (GT) 3 has emerged as a difficultto- treat viral strain, achieving Sustained Virologic Response (SVR) rates lower than other genotypes. Data about GT3-infected HIV patients are scarce either from clinical trials or real life. Describe the outcome of GT3 co-infected individuals treated with DAA; explore factors associated with virological failure.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
